Table 1.
The comparisons of baseline information between effective and in-effective group.
| All patients (n = 125) | Effective group (n = 68) | In-effective group (n = 57) | P | |
|---|---|---|---|---|
| Age (years) | 50.0 ± 17.4 | 46.6 ± 17.5 | 54.1 ± 16.5 | 0.015* |
| BMI (kg/m2) | 24.5 ± 3.2 | 24.4 ± 3.3 | 24.7 ± 3.0 | 0.632 |
| Affected side (left) | 62 | 34 | 28 | 1.000 |
| Sex (female) | 63 | 32 | 31 | 0.474 |
| Onset-therapy (days) | 10.38 ± 9.44 | 9.59 ± 8.81 | 11.32 ± 10.15 | 0.310 |
| PTA (dB) | 106.9 ± 14.1 | 107.3 ± 13.7 | 106.3 ± 14.5 | 0.694 |
| WBC | 8.5 ± 3.0 | 8.7 ± 3.2 | 8.3 ± 2.8 | 0.432 |
| NEU | 6.1 ± 2.9 | 6.4 ± 3.1 | 5.8 ± 2.6 | 0.330 |
| NLR | 3.9 ± 2.7 | 4.3 ± 2.9 | 3.5 ± 2.4 | 0.131 |
| PIT | 231.4 ± 60.1 | 240.9 ± 62.0 | 220.1 ± 56.2 | 0.051 |
| PLR | 146.2 ± 8.0 | 160.1 ± 94.3 | 129.8 ± 56.2 | 0.028* |
| MONO | 0.4 ± 0.2 | 0.4 ± 0.2 | 0.4 ± 0.2 | 0.979 |
| FIB | 216.3 ± 105.0 | 197.6 ± 100.8 | 238.6 ± 106.4 | 0.030* |
| Dizziness (Yes) | 68 | 34 | 34 | 0.367 |
| Tinnitus (Yes) | 105 | 61 | 47 | 0.298 |
| Diabetes (Yes) | 21 | 11 | 10 | 1.000 |
| Hypertension (Yes) | 35 | 21 | 14 | 0.549 |
| Hyperlipemia (Yes) | 15 | 7 | 8 | 0.585 |
BMI, body mass index; PTA, pure tone average hearing thresholds; WBC, white blood cell count; NEU, neutrophil count; NLR, neutrophil/lymphocyte count ratio; PIT, platelet count; PLR, platelet/lymphocyte count ratio; MONO, monocyte count; FIB, fibrinogen level.
*P < 0.05.